U.S. Markets open in 1 hr 59 mins
  • S&P Futures

    4,580.50
    +9.25 (+0.20%)
     
  • Dow Futures

    35,305.00
    +46.00 (+0.13%)
     
  • Nasdaq Futures

    15,245.75
    +39.75 (+0.26%)
     
  • Russell 2000 Futures

    2,098.40
    +6.30 (+0.30%)
     
  • Crude Oil

    86.66
    +1.23 (+1.44%)
     
  • Gold

    1,818.60
    +6.20 (+0.34%)
     
  • Silver

    23.81
    +0.32 (+1.35%)
     
  • EUR/USD

    1.1344
    +0.0014 (+0.1248%)
     
  • 10-Yr Bond

    1.8650
    0.0000 (0.00%)
     
  • Vix

    22.06
    +2.87 (+14.96%)
     
  • GBP/USD

    1.3631
    +0.0032 (+0.2385%)
     
  • USD/JPY

    114.4240
    -0.1610 (-0.1405%)
     
  • BTC-USD

    42,103.44
    +334.20 (+0.80%)
     
  • CMC Crypto 200

    998.89
    -10.49 (-1.04%)
     
  • FTSE 100

    7,589.01
    +25.46 (+0.34%)
     
  • Nikkei 225

    27,467.23
    -790.02 (-2.80%)
     

Would Shareholders Who Purchased MEDNAX's (NYSE:MD) Stock Five Years Be Happy With The Share price Today?

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. Imagine if you held MEDNAX, Inc. (NYSE:MD) for half a decade as the share price tanked 81%. And it's not just long term holders hurting, because the stock is down 34% in the last year. Even worse, it's down 19% in about a month, which isn't fun at all.

While a drop like that is definitely a body blow, money isn't as important as health and happiness.

Check out our latest analysis for MEDNAX

To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

Over five years MEDNAX's earnings per share dropped significantly, falling to a loss, with the share price also lower. The recent extraordinary items contributed to this situation. At present it's hard to make valid comparisons between EPS and the share price. But we would generally expect a lower price, given the situation.

The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).

earnings-per-share-growth
earnings-per-share-growth

Dive deeper into MEDNAX's key metrics by checking this interactive graph of MEDNAX's earnings, revenue and cash flow.

A Different Perspective

MEDNAX shareholders are down 34% for the year, but the market itself is up 23%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 13% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Like risks, for instance. Every company has them, and we've spotted 3 warning signs for MEDNAX (of which 1 is a bit concerning!) you should know about.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.